Diabmed Dr. Popescu Alexandrina S.R.L.
- Address
- Strada Transilvaniei Nr.20, 100179 Ploieşti, Romania
Cardiovascular Disease Research
At Diabmed Dr. Popescu Alexandrina S.R.L. in Ploiesti, clinical trials in cardiovascular diseases focus on major conditions such as heart failure and broader cardiovascular disease risk in people with metabolic disorders. These studies are designed to evaluate new treatment options that may help reduce serious heart-related events and improve long-term cardiovascular outcomes.
- Prevention of heart failure and cardiovascular death
- Reducing the risk of major adverse cardiovascular events
- Assessing whether new therapies can improve protection for high-risk patients
The research reflects a strong interest in linking cardiovascular health with diabetes and obesity care, aiming to support better prevention and treatment strategies.
Hormonal and Diabetes Research
This site also conducts trials in hormonal diseases, with a clear emphasis on type 1 diabetes and type 2 diabetes. The studies are exploring ways to improve blood sugar control, compare treatment effectiveness, and test whether newer therapies can offer better day-to-day management for people living with diabetes.
- Improving glycaemic control in type 1 diabetes
- Comparing treatments for type 2 diabetes mellitus
- Evaluating new options for people with difficult-to-control diabetes
These trials support ongoing efforts to make diabetes care more effective, practical, and tailored to patient needs.
Nutritional and Metabolic Disease Studies
Research in nutritional and metabolic diseases at this clinic includes obesity, overweight, and related metabolic conditions such as chronic kidney disease in people with diabetes. The trials are examining therapies that may help with weight reduction, metabolic control, and broader health benefits in patients affected by excess weight and diabetes.
- Testing treatments for overweight and obesity
- Studying weight loss alongside improved blood sugar control
- Exploring metabolic therapies for patients with type 2 diabetes
The Romanian site is contributing to research that connects weight management with diabetes and metabolic health, helping to advance care for common chronic conditions.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 2 by active trials.
- 1AstraZeneca AB1active
lock +1 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Novo Nordisk A/S3trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 442 other sites in Romania
Therapeutic Area Benchmark — Romania
Select a therapeutic area to compare against other sites in Romania.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Romania
Market Share
Country: Romania
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Diabmed Dr. Popescu Alexandrina S.R.L.
lock Showing 1 of 6 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Safety Comparison of Once-Weekly Insulin Icodec Versus Once-Daily Insulin Glargine U100 with Insulin Aspart in Adults with Type 1 Diabetes | Novo Nordisk A/S | Phase III | Not Recruiting | Aug 2025 | — |
IMP list
lock Showing 1 of 11 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Dapagliflozin | 3 | Unknown | 2023-08-02 | 2025-05-06 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.